Among patients with advanced melanoma treated with ipilimumab (Yervoy) and nivolumab (Opdivo), decreasing values of circulating tumor DNA (ctDNA) in tumor-informed liquid biopsies during the first 6 weeks of therapy were associated with improved survival outcomes, a recent study showed.
Of Interest
Melanoma in Adolescents and Young Adults: Declining Incidence, Rising Mortality
Melanoma in adolescents and young adults (AYAs) has distinct epidemiologic characteristics, with a declining incidence over the past 2 decades but an increasing trend in all-cause and cancer-specific mortality among specific populations, according to study results published in Clinics in Dermatology.
AI, Other Technologies May Help Narrow Gender Disparities in Melanoma
Men with melanoma tend to be diagnosed later and have worse outcomes. Artificial intelligence can help change that, a review suggests.
Study Reveals New Clues Into Childhood Cancer Survivors’ Increased Risk of Melanoma
Childhood cancer survivors have a more than two-fold increased risk of developing melanoma during their lifetime, compared to the general population, as well as a two-fold increased risk of death associated with a melanoma diagnosis. So reported a team of researchers in the Journal of Clinical Oncology.